DistantNews

US CDC will not publish report showing COVID vaccine effectiveness

From Jerusalem Post · (1d ago) English

Summarized and contextualized by DistantNews.

TLDR

  • A report detailing the efficacy of COVID-19 vaccines has been prevented from publication in the CDC's Morbidity and Mortality Weekly Report (MMWR).
  • HHS spokesperson Andrew Nixon cited concerns over the "methodological approach estimating vaccine effectiveness" as the reason for the manuscript's rejection.
  • This decision follows recent challenges in COVID vaccine research, including Pfizer halting a trial and a panel scrapping broad recommendations for COVID shots.

The U.S. Centers for Disease Control and Prevention (CDC) has reportedly blocked the publication of a scientific report that demonstrated the effectiveness of COVID-19 vaccines. The manuscript, intended for the CDC's flagship journal, the Morbidity and Mortality Weekly Report (MMWR), was not accepted due to concerns about its methodology, according to an HHS spokesperson.

Scientific reports are routinely reviewed at multiple levels to ensure they meet the highest standards before publication.

— Andrew NixonHHS spokesperson explaining the review process for scientific reports.

Andrew Nixon, an HHS spokesperson, stated that "Scientific reports are routinely reviewed at multiple levels to ensure they meet the highest standards before publication." He elaborated that "methodological approach estimating vaccine effectiveness" led to the manuscript not being accepted. The MMWR is a critical publication for disseminating public health findings and guidance, making this decision notable for researchers and health officials.

The Washington Post initially reported that the CDC had delayed the publication of this report, which indicated that the vaccines had halved emergency department visits and hospitalizations among healthy adults during the past winter. This development occurs amidst a backdrop of increasing challenges for COVID vaccine research.

the manuscript was not accepted for publication

— Andrew NixonHHS spokesperson stating the outcome for the vaccine effectiveness report.

Notably, Pfizer and BioNTech recently halted a large U.S. trial of their updated COVID shot in healthy adults aged 50 to 64 due to low enrollment. Furthermore, under Health Secretary Robert F. Kennedy Jr.'s leadership, a panel of vaccine advisers had previously scrapped a broad recommendation for COVID shots, suggesting they be administered only through shared decision-making with a healthcare provider. This recommendation has since been temporarily blocked by a federal judge.

methodological approach estimating vaccine effectiveness

— Andrew NixonThe specific concern cited for rejecting the vaccine effectiveness report.
DistantNews Editorial

Originally published by Jerusalem Post. Summarized and contextualized by our editorial team with added local perspective. Read our editorial standards.